v3.22.2.2
Condensed Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Operating expenses:        
Research and development $ 1,622,374 $ 2,961,122 $ 6,797,914 $ 7,877,281
General and administrative expenses 969,946 1,150,369 3,427,679 3,576,101
Total operating expenses 2,592,320 4,111,491 10,225,593 11,453,382
Loss from operations (2,592,320) (4,111,491) (10,225,593) (11,453,382)
Other income:        
Interest income 16,605 1,509 22,315 4,405
Total other income 16,605 1,509 22,315 4,405
Loss before income taxes (2,575,715) (4,109,982) (10,203,278) (11,448,977)
Net loss $ (2,575,715) $ (4,109,982) $ (10,203,278) $ (11,448,977)
Basic net loss per share $ (0.28) $ (0.49) $ (1.18) $ (1.37)
Diluted net loss per share $ (0.28) $ (0.49) $ (1.18) $ (1.37)
Weighted average number of shares outstanding - basic 9,199,955 8,330,390 8,623,430 8,328,946
Weighted average number of shares outstanding - diluted 9,199,955 8,330,390 8,623,430 8,328,946

Source